MRK logo Merck & Co. +
Merck & Co.
+

Merck & Co. (MRK) Business News

Track Merck & Co. in real time with a live news feed covering Merck & Co. stock news, official press releases, company announcements, and an archive of historical Merck & Co. news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
10:01 AM | Thursday | May 14, 2026 Zacks Investment Research

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

News Thumbnail
10:01 AM | Thursday | May 14, 2026 Zacks Investment Research

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

News Thumbnail
12:52 PM | Wednesday | May 13, 2026 Zacks Investment Research

Will Keytruda Continue to Aid MRK's Growth in 2026 After a Strong Q1?

News Thumbnail
6:45 AM | Tuesday | May 12, 2026 Business Wire

Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026

News Thumbnail
5:36 AM | Tuesday | May 12, 2026 Zacks Investment Research

The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex

News Thumbnail
12:21 PM | Monday | May 11, 2026 Zacks Investment Research

Merck Stock Down 7% in a Month: Should Investors Hold or Exit?

News Thumbnail
1:30 PM | Friday | May 8, 2026 The Motley Fool

2 Dividend Stocks to Double Up On Right Now

News Thumbnail
1:22 PM | Friday | May 8, 2026 GuruFocus

Merck Faces Gardasil Trial After $8.9 Billion Sales Peak

News Thumbnail
2:05 PM | Thursday | May 7, 2026 Business Wire

Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate

News Thumbnail
10:32 AM | Wednesday | May 6, 2026 24/7 Wall Street

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash

News Thumbnail
9:00 AM | Wednesday | May 6, 2026 Business Wire

Merck Animal Health Selects Salesforce's Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees

News Thumbnail

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

10:01 AM | Thursday | May 14, 2026

news photo
Loading...

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

Read full article redirect
10:01 AM | Thursday | May 14, 2026

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

Read full article arrow
News Thumbnail
10:01 AM | Thursday | May 14, 2026

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

Read full article arrow
News Thumbnail
12:52 PM | Wednesday | May 13, 2026

Will Keytruda Continue to Aid MRK's Growth in 2026 After a Strong Q1?

Zacks Investment Research

Keytruda aids Merck's Q1 performance with $8B in sales. New indications plus combo therapies could fuel the drug's overall growth through 2026.

Read full article arrow
News Thumbnail
6:45 AM | Tuesday | May 12, 2026

Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026

Business Wire

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 abstracts across over 25 types of cancer from the company's comprehensive oncology portfolio and pipeline will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-June 2). The data reinforce the long-term impact of KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, and Merck's rapidly advancing pipelin.

Read full article arrow
News Thumbnail
5:36 AM | Tuesday | May 12, 2026

The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex

Zacks Investment Research

UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.

Read full article arrow
News Thumbnail
12:21 PM | Monday | May 11, 2026

Merck Stock Down 7% in a Month: Should Investors Hold or Exit?

Zacks Investment Research

Merck falls 7% despite an earnings beat as a pipeline setback and Gardasil weakness act as dampeners. However, Keytruda and new launches support growth.

Read full article arrow
News Thumbnail
1:30 PM | Friday | May 8, 2026

2 Dividend Stocks to Double Up On Right Now

The Motley Fool

Amgen is handling a recent patent cliff pretty well. Merck is well prepared for its own upcoming patent cliff.

Read full article arrow
News Thumbnail
1:22 PM | Friday | May 8, 2026

Merck Faces Gardasil Trial After $8.9 Billion Sales Peak

GuruFocus

Merck (MRK) is moving toward a potentially high-stakes courtroom test over Gardasil, its HPV vaccine, as personal injury lawyers try to convince a Los Angeles j

Read full article arrow
News Thumbnail
2:05 PM | Thursday | May 7, 2026

Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate

Business Wire

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today the publication of work describing the large-scale synthesis of enlicitide decanoate, the company's investigational oral PCSK9 inhibitor, using a tailored suite of enzymes in the latest issue of the peer reviewed journal Science. “Macrocyclic peptides have the potential to unlock new opportunities to develop oral treatment options for challenging therapeutic targets and broaden p.

Read full article arrow
News Thumbnail
10:32 AM | Wednesday | May 6, 2026

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash

24/7 Wall Street

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest source outside a paycheck.

Read full article arrow
News Thumbnail
9:00 AM | Wednesday | May 6, 2026

Merck Animal Health Selects Salesforce's Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees

Business Wire

SAN FRANCISCO & RAHWAY, N.J.--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world's #1 AI CRM, and Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc. (NYSE: MRK), today announced that Merck Animal Health has selected Agentforce Life Sciences for Customer Engagement to create a unified, 360-degree view and support experience for veterinarians, pet owners, and production animal farmers across all channels.
Leveraging Agentfo.

Read full article arrow
News Thumbnail